Apotex Health Corp APTX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- CA$30.54
- Day Range
- CA$30.27–30.89
- 52-Week Range
- CA$26.05–40.18
- Bid/Ask
- CA$30.75 / CA$30.99
- Shares Outstanding
- 228.50M
- Market Cap
- CA$7.04B
- Volume/Avg
- 242,303 / 489,521
Key Statistics
- Price/Earnings (Normalized)
- 20.04
- Price/Sales
- 2.14
- Dividend Yield (Trailing)
- 0.19%
- Dividend Yield (Forward)
- 0.19%
- Dividend Payment Schedule
- Sep
- Total Yield
- 0.19%
Company Profile
Apotex Health Corp is a Canadian-based health company with a broad portfolio of generic, biosimilar and branded pharmaceuticals, as well as branded consumer health and wellness products. Its business lines include Conventional Generics, Specialty Generics and Brands & Biosimilars. The maximum revenue is derived from the Conventional Generics business, which are off-patent, small molecule oral solid dose pharmaceuticals that are bioequivalent to branded pharmaceuticals. It has three geographic operating segments: (i) Canada; (ii) the U.S.; and (iii) International. The majority of revenue is derived from Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- —
- Website
- https://www.apotex.com
Valuation
|
Metric
|
APTX
|
|---|---|
Price/Earnings (Normalized) | 20.04 |
Price/Book Value | 20.09 |
Price/Sales | 2.14 |
Price/Cash Flow | 26.93 |
Price/Earnings
APTX
Financial Strength
|
Metric
|
APTX
|
|---|---|
Quick Ratio | 0.94 |
Current Ratio | 1.77 |
Interest Coverage | 1.17 |
Quick Ratio
APTX
Profitability
|
Metric
|
APTX
|
|---|---|
Return on Assets (Normalized) | 7.33% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 17.46% |
Return on Assets
APTX
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|v@#KmDs | LOCK|hF>&q | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|?K#<#M<< | LOCK|J&Z$ | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|%N<G&#k | LOCK|dVC | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|>jP>tc>S | LOCK|lF | $31B | |||
| Viatris Inc
VTRS
| LOCK|bz$B?LV | LOCK|^K< | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|#< | LOCK|^^ | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|w^#v%$< | LOCK|%? | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|$@l%mbd | LOCK|TCn | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|%$gR!c^ | LOCK|??Jb! | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|B@^!m< | LOCK|htz | $2B |
United States